FOXNews.com: GlaxoSmithKline starts final-stage tests on severe asthma drug

FOXNews.com FOX News Network - We Report. You Decide. // via fulltextrssfeed.com

GlaxoSmithKline starts final-stage tests on severe asthma drug Oct 29th 2012, 15:19 Published October 29, 2012 Reuters GlaxoSmithKline has started final-stage testing of an experimental drug for treating severe asthma, Britain's biggest drugmaker said on Monday. The move to progress the injectable antibody treatment mepolizumab into Phase III trials had been expected after an earlier study showed it nearly halved the number of attacks suffered by patients. Severe refractory asthma only affects around 4 percent of patients with the disease, so the drug may not become a major seller for GSK but could consolidate the group's strong grip on the market for lung drugs.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions